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Regulatory T (Treg) cells are essential for maintaining immune tolerance. In this issue of Immunity, Haribhai
et al. (2011) demonstrate that both subsets of Treg cells, natural and induced, are necessary to achieve
tolerance, probably because of their nonoverlapping T cell receptor repertoires.It is indisputable that regulatory T (Treg)
cells are essential to downmodulate auto-
immune and other inflammatory diseases.
The most dominant group of Treg cells is
characterized by the expression of the
transcription factor forkhead box P3
(Foxp3). Foxp3 is not only important for
Treg cell development and maintenance
but also for their suppressive function.
Defective development of Treg cells in
humans with FOXP3 mutations leads to
the life-threatening autoimmune condition
immune dysregulation, polyendocrinop-
athy, enteropathy, and X-linked (IPEX)
syndrome (Bennett et al., 2001; Wildin
et al., 2001). Similarly, a lethal disease is
observed in Foxp3-deficient mice, which
lack Treg cells (Brunkow et al., 2001).
Foxp3+ Treg cells can be divided in two
major subsets: natural Treg (nTreg) cells
are generated in the thymus through
high-avidity interactionsmediated by their
T cell receptor (TCR), and inducible or
adaptive Treg (iTreg) cells differentiate in
the periphery from Foxp3 conventional
T (Tconv) cells, (Curotto de Lafaille and
Lafaille, 2009). The relative contributions
of nTreg and iTreg cells in the establish-
ment and maintenance of immune toler-
ance is a major unresolved issue. It is still
not known whether nTreg and iTreg cells
have redundant roles, distinct roles in
different situations, or whether they act
in concert to achieve immunoregulation.
Using a monoclonal mouse model
devoid of nTreg cells but capable (or not)
of developing antigen-specific iTreg cells,
we showed that iTreg cell generation is
sufficient to establish mucosal tolerance
and prevent chronic lung inflammation
(Mucida et al., 2005; Curotto de Lafaille
et al., 2008). These data indicated that
iTreg cells do not need nTreg cells to
achieve mucosal tolerance. In contrast,6 Immunity 35, July 22, 2011 ª2011 ElsevierHaribhai et al., (2009) have previously
shown that iTreg cell generation is benefi-
cial and prevent excessive inflammation
in a transfer colitis model, but it is not
sufficient to prevent disease. Only the
combination of nTreg and in vitro-gener-
ated iTreg cells could fully protect mice
that received naive T cells that were
unable to generate in vivo iTreg cells
(from Foxp3-deficient donors). Thus, in
this colitis model, both nTreg and iTreg
cells were required for protection from
disease.
In this issue of Immunity, Haribhai et al.
(2011) took a step forward and provided
new insight into the roles of nTreg and
iTreg cells in tolerance. They studied the
prevention of lethality, lymphoprolifera-
tion, and autoimmune disease in Foxp3-
deficient mice. If left untreated, these
mice die at 3 weeks of age on the
BALB/c background. Neonatal injection
of wild-type (WT) CD4+ T cells efficiently
prevented disease. The authors then
investigated whether nTreg cells alone
could prevent disease. Although there
was a very substantial reduction in
lethality, the mice still displayed signs of
inflammation. They noted that addition of
Tconv to nTreg cells, paradoxically,
improved the outcome. Tconv cells are
the source of Teff cells, which could
become pathogenic in Foxp3-deficient
host animals. But Tconv cells can also
differentiate in vivo into iTreg cells. When
the authors added Tconv cells from
Foxp3-deficient mice, these Tconv cells
no longer supplemented nTregs cells,
showing the importance of iTreg cells in
the protection. Haribhai et al. (2011) then
elegantly showed that the rescue from
disease is dependent on iTreg cells
because selective depletion of Foxp3+
iTreg cells from mice cotransferredInc.with congenic nTreg and Tconv cells led
to incomplete disease rescue. Thus,
together, iTreg and nTreg cells prevent
disease better than either subset alone.
These observations have important
consequences and raise issues for future
studies. By virtue of the protocols used
for cell isolation (Foxp3GFP+ cells from
WT donor mice), the nTreg population is
certain to contain some iTreg cells. Yet,
despite the presence of iTreg cells, these
nTreg cells did not confer full protection.
One possibility to explain these results is
that iTreg cell conversion induced in the
Foxp3-deficient hosts was necessary.
The nTreg cell population of WT mice
contains iTreg cells, but those were
generated in a different environment. It is
possible that these WT iTreg cells were
inadequate to prevent disease in Foxp3-
deficient mice; for instance, they might
have lacked the required TCR specific-
ities. However, a more likely explanation
is that the absolute numbers of iTreg cells
injected as part of the nTreg cell inoculum
was low. In fact, the highest total number
of ‘‘nTreg’’ transferred was 106 cells/
mouse. It is possible that higher doses
of nTreg cells would have contained suffi-
cient numbers of iTreg cells to confer full
protection.
To further probe the role of iTreg cells,
Haribhai et al. (2011) tested in vitro-gener-
ated iTreg cells. Polyclonal in vitro-gener-
ated iTreg cells could largely substitute for
iTreg cells derived in vivo from Tconv
cells. The two sources of iTreg cells
were functionally equivalent, even though
iTreg cell generation from the latter source
is tailored by the host, a situation that
does not occur when Treg cells are gener-
ated in vitro by T cell receptor (TCR) stim-
ulation. In the context of an equivalent
rescue of Foxp3-deficient animals by
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Figure 1. Natural and Induced Treg Cells Join Forces to Maintain Immune Tolerance
Inflammatory responses are kept in check by a collaborative work between nTreg and iTreg cells. nTreg
and iTreg cells, through nonoverlapping TCR repertoires, may recognize a distinct set of antigens that can
help them better control effector T cell responses. The following abbreviations are used: Tconv, conven-
tional T cells; Teff, effector T cells; nTreg, natural regulatory T cells; iTreg, induced regulatory T cells; APC,
antigen-presenting cells; TCR, T cell receptor; MHC II, major complex of histocompatibility class II.
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Previewsin vitro iTreg and in vivo-derived iTreg
cells, the comparison of gene expression
profile of both iTreg cell sources was
very interesting: the vast differences in
gene expression between iTreg cells
generated in vitro or in vivo points out to
a relatively small number of genes whose
shared expression confers the capacity to
protect, with Foxp3 being one of those.
Alternatively, the in vitro-generated iTreg
cells modify their expression profile
in vivo; in this case, the comparison of
in vivo-protective, in vitro-generated iTreg
cells with the original in vitro-generated
iTreg cell population could point toward
the relevant differences associated with
the acquisition of the capacity to protect.
Also interesting is the genetic and
epigenetic information gathered from the
study of the in vivo-generated iTreg cells,
which are generated from Tconv cells in
the process of preventing disease in
Foxp3-deficient mice. Even though these
iTreg cells have a highly overlapping
gene expression profile with nTreg cells,
they differ from other sources of iTreg
cells. For example, the degree of methyl-
ation of the Foxp3 locus at the TSDR
(CNS2) is very high, in contrast to the iTreg
cells reported by Polansky et al. (2008).
Similarly, the vast majority of the in vivo-generated iTreg cells described in this
manuscript express high amounts of
Helios, in contrast to a previous report
showing that iTreg cells are largely nega-
tive for Helios expression (Thornton
et al., 2010). It will be very important to
clarify all these discrepancies as soon as
possible, in order to filter out some con-
founding factors from what is relevant
regarding these different cell types.
The mechanism to explain why both
nTreg and iTreg cells are necessary to
achieve full tolerance could be based on
the TCR studies that the authors con-
ducted. In these studies, they showed
that the repertoires of nTreg and iTreg
cells were largely nonoverlapping. If
a set of antigens needs to be recognized
by Treg cells and the Treg cell TCR reper-
toires are nonoverlapping, it is possible
that each Treg cell subset is responsible
for recognizing different antigens. Hence,
neither of the two Treg cell subsets, in
isolation of the other, would be able to
accomplish the complete task (Figure 1).
One of the caveats of the authors’ anal-
ysis is that the TCR specificity is deter-
mined by ab TCR pairs, and the authors
analyzed TCR-b chains without fixing the
TCR-a. Thus, the same TCR-b can recog-
nize different antigens if paired withImmudifferent TCR-a. Furthermore, as the
authors highlight, there is a difference
between TCR repertoire and antigen
recognition because the same TCR could
cross-react with more than one antigen
and the same antigen could be recog-
nized by many different TCRs.
If the nonoverlapping TCR specificities
of nTreg and iTreg cells do not solely
explain the need for both Treg cell types,
then nTreg and iTreg cells could use
different suppressive mechanisms, which
may even target different aspects of the
effector response. If this is the case,
what are the different mechanisms?
These questions are not easy to answer,
but getting on the right track is extremely
important. The work by Haribhai et al.
(2011) has several additional implications.
Assuming that human Treg cells and
rodent Treg cells behave similarly
regarding a division of labor between
nTreg and iTreg cells (as they have been
shown to be similar in most relevant
aspects of Treg cell biology) the data pre-
sented by Haribhai et al. (2011) cannot
escape the attention of investigators
designing clinical trials, given that they
would have to include both sources of
Treg cells for full therapeutic effect, or
nTreg and a source of Tconv cells that
does not have the capacity to induce
harm. Alternatively, they would focus
selectively on nTreg or iTreg cells to
accomplish different clinical outcomes.
Haribhai et al.’s data show that the
roles of nTreg and iTreg cells are not
overlapping; instead, they complement
each other for the protection of Foxp3-
deficient mice. Thus, nTreg and iTreg
cells are both required for complete
protection from lymphoproliferation, auto-
immune disease, and inflammation-
induced lethality. Future experiments
allowing the differential labeling of pure
nTreg and iTreg cells will help better
define the role each subtype plays during
different kinds of immune responses.REFERENCES
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Sensing pathogens is an essential first step in the initiation of a host response to infection. In this issue of
Immunity, Kane et al. (2011) used mouse models to demonstrate that Toll-like receptor 7 is required for
the generation of an antibody response to infection by retroviruses.There are two main classes of sensors
that detect the presence of nucleic acid
components of invading pathogens within
cells (McCartney and Colonna, 2009): the
cytosolic retinoic acid-inducible gene I
(RIG-I)-like receptors (RLRs), which
include LGP2, MDA5, and RIG-I, all of
which are activated by RNA, and the en-
dosomal Toll-like receptors (TLRs). Of
the endosomal TLRs (TLR3, TLR7, TLR8,
and TLR9), TLR3 senses dsRNA, TLR7
and TLR8 recognize ssRNA, and TLR9 is
activated by unmethylated CpG-contain-
ing DNA, which can be found in both
bacterial and certain viral pathogens.
Activation of either cytoplasmic or endo-
somal sensors results in the production
of type 1 interferon (IFN) and inflammatory
cytokines, with dendritic cells (DCs) being
key orchestrators of this innate response
(Gilliet et al., 2008). These cytokines in
turn induce the expression of an array of
genes, the products of which may have
either direct antiviral effects or promote
adaptive immune responses.
As Kane et al. (2011) rightly point out in
this issue of Immunity, the ability of the
various sensors to detect the presence
of certain nucleic acids in vitro is not
necessarily predictive of relevance in the
context of infection in vivo, and so theyemployed mouse models to determine
what might be relevant in vivo sensors of
infection by retroviruses. Mouse strains
vary in their ability to control retroviral
infections through innate and adaptive
immune responses. Thus, beginning with
the reasonable premise that mouse
strains that effectively control retroviral
infections are more likely to be competent
for both sensing and responding to these
pathogens, Kane et al. examined the viral
and host requirements for mobilization of
an antiviral adaptive immune response,
asmeasured by the production of antiviral
antibodies and control of viral replication,
in such strains.
The particular mouse strains used by
Kane et al. included I/LnJ mice, which
are able to control the replication of two
unrelated retroviruses, namely the gam-
maretrovirus murine leukemia virus
(MuLV) and the betaretrovirus mouse
mammary tumor tirus (MMTV). Another
mouse strain, C57BL/6J (B6), is able to
control the replication of MuLV. Both
humoral and cellular immune responses
probably contribute to control of retroviral
infection, but in this study, Kane et al.
focused on the humoral response. Impor-
tantly, by comparing mouse strains that
do, or do not, effectively control MuLVand/or MMTV replication, they show that
the ability to control viral replication corre-
lates well with the ability of a given mouse
strain to mount a robust humoral immune
response to each virus.
To understand what component of the
virus and what aspects of viral replication
might be crucial for viral sensing and
immune control, Kane et al. compared
humoral immune responses to replicating
and inactivated viruses. Whereas MMTV
replication enabled sensing of the virus,
and a humoral immune response in
I/LnJ hosts, heat-inactivated (and thus
replication-defective) MMTV was able to
elicit MMTV antibodies mice only in the
presence of complete Freund’s adjuvant
(CFA), suggesting that CFA is able to
complement for signals generated by viral
replication. Presumably, such signals are
missing, or ineffective, when heat-inacti-
vated virus preparations alone are used
as immunogens.
Importantly, however, UV-inactivated
viruses (which are physically intact, could
enter cells, and were detected in endo-
somes, but could not replicate in vivo)
were capable of eliciting antiviral anti-
bodies when injected into I/LnJ mice.
Kane et al. were able to rule out a require-
ment for the endosomal dsRNA sensor
